179 related articles for article (PubMed ID: 23355910)
1. Is nonalcoholic fatty liver disease the hepatic expression of the metabolic syndrome?
Yilmaz Y
World J Hepatol; 2012 Dec; 4(12):332-4. PubMed ID: 23355910
[TBL] [Abstract][Full Text] [Related]
2. NAFLD in the absence of metabolic syndrome: different epidemiology, pathogenetic mechanisms, risk factors for disease progression?
Yilmaz Y
Semin Liver Dis; 2012 Feb; 32(1):14-21. PubMed ID: 22418884
[TBL] [Abstract][Full Text] [Related]
3. Common features of the metabolic syndrome and nonalcoholic fatty liver disease.
Almeda-Valdes P; Aguilar-Olivos N; Uribe M; Méndez-Sánchez N
Rev Recent Clin Trials; 2014; 9(3):148-58. PubMed ID: 25514910
[TBL] [Abstract][Full Text] [Related]
4. Metabolic aspects of adult patients with nonalcoholic fatty liver disease.
Abenavoli L; Milic N; Di Renzo L; Preveden T; Medić-Stojanoska M; De Lorenzo A
World J Gastroenterol; 2016 Aug; 22(31):7006-16. PubMed ID: 27610012
[TBL] [Abstract][Full Text] [Related]
5. Metabolic syndrome and nonalcoholic fatty liver disease: Is insulin resistance the link?
Asrih M; Jornayvaz FR
Mol Cell Endocrinol; 2015 Dec; 418 Pt 1():55-65. PubMed ID: 25724480
[TBL] [Abstract][Full Text] [Related]
6. Examining the Relationship Between Nonalcoholic Fatty Liver Disease and the Metabolic Syndrome in Nondiabetic Subjects.
Preuss HG; Kaats GR; Mrvichin N; Swaroop A; Bagchi D; Clouatre D; Preuss JM
J Am Coll Nutr; 2018 Aug; 37(6):457-465. PubMed ID: 29652564
[TBL] [Abstract][Full Text] [Related]
7. Duodenal-jejunal bypass improves nonalcoholic fatty liver disease independently of weight loss in rodents with diet-induced obesity.
Angelini G; Castagneto-Gissey L; Casella-Mariolo J; Caristo ME; Russo MF; Lembo E; Verrastro O; Stefanizzi G; Marini PL; Casella G; Bornstein SR; Rubino F; Mingrone G
Am J Physiol Gastrointest Liver Physiol; 2020 Oct; 319(4):G502-G511. PubMed ID: 32812775
[TBL] [Abstract][Full Text] [Related]
8. Clinical epidemiology and disease burden of nonalcoholic fatty liver disease.
Perumpail BJ; Khan MA; Yoo ER; Cholankeril G; Kim D; Ahmed A
World J Gastroenterol; 2017 Dec; 23(47):8263-8276. PubMed ID: 29307986
[TBL] [Abstract][Full Text] [Related]
9. The role of hepatic fat accumulation in pathogenesis of non-alcoholic fatty liver disease (NAFLD).
Liu Q; Bengmark S; Qu S
Lipids Health Dis; 2010 Apr; 9():42. PubMed ID: 20426802
[TBL] [Abstract][Full Text] [Related]
10. Pathogenesis of Insulin Resistance and Atherogenic Dyslipidemia in Nonalcoholic Fatty Liver Disease.
Akhtar DH; Iqbal U; Vazquez-Montesino LM; Dennis BB; Ahmed A
J Clin Transl Hepatol; 2019 Dec; 7(4):362-370. PubMed ID: 31915606
[TBL] [Abstract][Full Text] [Related]
11. Fibrosis in genotype 3 chronic hepatitis C and nonalcoholic fatty liver disease: Role of insulin resistance and hepatic steatosis.
Bugianesi E; Marchesini G; Gentilcore E; Cua IH; Vanni E; Rizzetto M; George J
Hepatology; 2006 Dec; 44(6):1648-55. PubMed ID: 17133473
[TBL] [Abstract][Full Text] [Related]
12. [Prevalence of nonalcoholic fatty liver disease and metabolic syndrome in obese children].
Shi HB; Fu JF; Liang L; Wang CL; Zhu JF; Zhou F; Zhao ZY
Zhonghua Er Ke Za Zhi; 2009 Feb; 47(2):114-8. PubMed ID: 19573457
[TBL] [Abstract][Full Text] [Related]
13. Association between metabolic syndrome and liver histology among children with nonalcoholic Fatty liver disease.
Patton HM; Yates K; Unalp-Arida A; Behling CA; Huang TT; Rosenthal P; Sanyal AJ; Schwimmer JB; Lavine JE
Am J Gastroenterol; 2010 Sep; 105(9):2093-102. PubMed ID: 20372110
[TBL] [Abstract][Full Text] [Related]
14. Insulin resistance in nonalcoholic fatty liver disease.
Bugianesi E; Moscatiello S; Ciaravella MF; Marchesini G
Curr Pharm Des; 2010 Jun; 16(17):1941-51. PubMed ID: 20370677
[TBL] [Abstract][Full Text] [Related]
15. The Epidemiology, Risk Profiling and Diagnostic Challenges of Nonalcoholic Fatty Liver Disease.
Iqbal U; Perumpail BJ; Akhtar D; Kim D; Ahmed A
Medicines (Basel); 2019 Mar; 6(1):. PubMed ID: 30889791
[TBL] [Abstract][Full Text] [Related]
16. Nonalcoholic fatty liver disease as a multi-systemic disease.
Fotbolcu H; Zorlu E
World J Gastroenterol; 2016 Apr; 22(16):4079-90. PubMed ID: 27122660
[TBL] [Abstract][Full Text] [Related]
17. Berberine improves glucogenesis and lipid metabolism in nonalcoholic fatty liver disease.
Zhao L; Cang Z; Sun H; Nie X; Wang N; Lu Y
BMC Endocr Disord; 2017 Feb; 17(1):13. PubMed ID: 28241817
[TBL] [Abstract][Full Text] [Related]
18. Characterization of nonalcoholic fatty liver disease unrelated to the metabolic syndrome.
Yilmaz Y; Senates E; Ayyildiz T; Colak Y; Tuncer I; Ovunc AO; Dolar E; Kalayci C
Eur J Clin Invest; 2012 Apr; 42(4):411-8. PubMed ID: 21913918
[TBL] [Abstract][Full Text] [Related]
19. Hepatocellular Carcinoma in the Setting of Non-cirrhotic Nonalcoholic Fatty Liver Disease and the Metabolic Syndrome: US Experience.
Perumpail RB; Wong RJ; Ahmed A; Harrison SA
Dig Dis Sci; 2015 Oct; 60(10):3142-8. PubMed ID: 26250831
[TBL] [Abstract][Full Text] [Related]
20. Non-alcoholic fatty liver disease, obesity and the metabolic syndrome.
Dietrich P; Hellerbrand C
Best Pract Res Clin Gastroenterol; 2014 Aug; 28(4):637-53. PubMed ID: 25194181
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
